HF
BLPH

HRT Financial’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

HRT Financial’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-28,035
Closed -$25K – 3621
2022
Q4 		$25K Buy
+28,035
New +$28.7K ﹤0.01% 2162
2021
Q4 		– Sell
-11,879
Closed -$48K – 4542
2021
Q3 		$48K Sell
11,879
-1,931
-14% -$8.05K ﹤0.01% 3054
2021
Q2 		$66K Buy
+13,810
New +$61.9K ﹤0.01% 2655

Other funds holding BLPH

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's BLPH Position: Q1 2023 in Review

HRT Financial sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q1 2023, closing a stake of 28,035 shares — an estimated $25K sold.

HRT Financial first reported a position in BLPH in Q2 2021 and held it in 3 quarters. The position peaked at $66K in Q2 2021. 19 funds tracked by Wall St. Rank hold BLPH as of Q1 2023.

  • HRT Financial reported no remaining Bellerophon Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 28,035 Bellerophon Therapeutics, Inc. shares in Q1 2023, an estimated $25K.
  • HRT Financial first reported a position in Bellerophon Therapeutics, Inc. in Q2 2021 and held it in 3 quarters.
  • HRT Financial's Bellerophon Therapeutics, Inc. position peaked at $66K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.